Does TUCATINIB Cause Neoplasm progression? 237 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 237 reports of Neoplasm progression have been filed in association with TUCATINIB (TUKYSA). This represents 3.9% of all adverse event reports for TUCATINIB.
237
Reports of Neoplasm progression with TUCATINIB
3.9%
of all TUCATINIB reports
35
Deaths
37
Hospitalizations
How Dangerous Is Neoplasm progression From TUCATINIB?
Of the 237 reports, 35 (14.8%) resulted in death, 37 (15.6%) required hospitalization, and 6 (2.5%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TUCATINIB. However, 237 reports have been filed with the FAERS database.
What Other Side Effects Does TUCATINIB Cause?
Diarrhoea (1,587)
Nausea (862)
Fatigue (843)
Vomiting (483)
Death (400)
Off label use (392)
Malignant neoplasm progression (361)
Palmar-plantar erythrodysaesthesia syndrome (355)
Product dose omission issue (332)
Asthenia (322)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which TUCATINIB Alternatives Have Lower Neoplasm progression Risk?
TUCATINIB vs TUCIDINOSTAT
TUCATINIB vs TYKERB
TUCATINIB vs TYLENOL
TUCATINIB vs TYROTHRICIN
TUCATINIB vs TYSABRI